AIDS and sexually transmitted diseases | Country profiles | Afghanistan HIV country profile

Afghanistan HIV country profile

Print PDF

Sociodemographic data

  • Population:  33.4 million; percentage of urban population: 27%
  • Births per 1000 population: 37
  • Deaths per 1000 population: 8 
  • Infant mortality rate: 68
  • Human development index rank: 171 (low)
  • Gross national income (per capita): US$ 1990 (low income)

HIV care cascade and progress towards 90-90-90

Fig_1._Afghanistan

Epidemiological data (2016)

HIV estimates and case notification

 

Estimated

Reported

HIV prevalence in general population

0.1

NA

People Living with HIV (PLHIV)

7500 [3900 – 19,000]

2131

New infections

204

AIDS related deaths

26

 

 

 

Fig_2

HIV in specific populations

 

Survey data

 

Size estimate

Routine testing and VCT data

Key populations

Prevalence

 

 

No tested

HIV+ cases (%)

Sex workers (SW)

0.2 (2012)

 

12500

131

0

Men having sex with men (MSM)

0.4 (2012)

 

10700

4123

21 (0.5%)

People who inject drugs (PWIDs)

4.4 (2012)

 

40900

13581

35 (0.2%)

Prisoners

NA

 

28000

9997

2 (.02%)

Populations in health settings

 

 

 

 

 

TB patients

 

 

 

3028

12 (0.4%)

Pregnant women

 

 

 

2167

4 (0.2%)

Blood Donors

 

 

 

128,167

0 (0%)

Clients of testing services

 

 

 

26789

134 (0.5%)

Response

Policy implementation

 

 

Policy CD4 threshold adults and adolescents

Treat all

Recommended initiation threshold  children

Treat all

Policy of lifelong ART to pregnant & breastfeeding women

Option B+

Implementation of lifelong ART to pregnant & breastfeeding women

Done in a small number of MCH sites

Implementation of national policy on viral load monitoring

Not implemented

HIV testing coverage in key populations *

Fig_3  Antiretroviral therapy and PMTCT coverage

Fig._4

References 

1 http://www.prb.org/pdf16/prb-wpds2016-web-2016.pdf; (2) WHO.EMRO Regional Surveillance Data; (3) WHO/UNAIDS data spectrum 2016; (4) Global AIDS Monitoring (GAM) 2016.*These are approximate estimations based on the latest available data for number of people tested and size estimates.